
|Videos|March 27, 2017
Several Actionable Targets Identified in Testicular Cancer
Author(s)Aditya Bagrodia, MD
This video highlights recent research in cisplatin-resistant testicular cancer, including a study on whole exome sequencing that revealed several actionable targets.
Advertisement
In this video, Aditya Bagrodia, MD, of the University of Texas Southwestern Medical Center, discusses recent research in germ cell tumors.
A recent study that used whole exome sequencing in platinum-resistant disease revealed that many of these patients have actionable targets.
Bagrodia, who gave a presentation on this topic at the 2017 Genitourinary Cancers Symposium in Orlando, Florida, also looks ahead toward trials examining the potential of different immunotherapies in this setting.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
2
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
3
GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology
4
Understanding The Training, Credentialing Landscapes for End-of-Life Doulas
5

























































